Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

IMRIS Inc.

IMRSQPNK
Healthcare
Medical - Specialties
$0.00
$0.00(0.00%)
U.S. Market opens in 11h 9m

IMRIS Inc. Fundamental Analysis

IMRIS Inc. (IMRSQ) shows weak financial fundamentals with a PE ratio of -0.00, profit margin of -1.05%, and ROE of -1.30%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position953896.22%
PEG Ratio-0.00

Areas of Concern

ROE-1.30%
Operating Margin-80.09%
We analyze IMRSQ's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -254.4/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-254.4/100

We analyze IMRSQ's fundamental strength across five key dimensions:

Efficiency Score

Weak

IMRSQ struggles to generate sufficient returns from assets.

ROA > 10%
-46.40%

Valuation Score

Excellent

IMRSQ trades at attractive valuation levels.

PE < 25
-0.00
PEG Ratio < 2
-0.00

Growth Score

Weak

IMRSQ faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Moderate

IMRSQ shows balanced financial health with some risks.

Debt/Equity < 1
1.99
Current Ratio > 1
1.10

Profitability Score

Weak

IMRSQ struggles to sustain strong margins.

ROE > 15%
-129.83%
Net Margin ≥ 15%
-1.05%
Positive Free Cash Flow
No

Key Financial Metrics

Is IMRSQ Expensive or Cheap?

P/E Ratio

IMRSQ trades at -0.00 times earnings. This suggests potential undervaluation.

-0.00

PEG Ratio

When adjusting for growth, IMRSQ's PEG of -0.00 indicates potential undervaluation.

-0.00

Price to Book

The market values IMRIS Inc. at 0.00 times its book value. This may indicate undervaluation.

0.00

EV/EBITDA

Enterprise value stands at 0.81 times EBITDA. This is generally considered low.

0.81

How Well Does IMRSQ Make Money?

Net Profit Margin

For every $100 in sales, IMRIS Inc. keeps $-1.05 as profit after all expenses.

-1.05%

Operating Margin

Core operations generate -80.09 in profit for every $100 in revenue, before interest and taxes.

-80.09%

ROE

Management delivers $-1.30 in profit for every $100 of shareholder equity.

-1.30%

ROA

IMRIS Inc. generates $-46.40 in profit for every $100 in assets, demonstrating efficient asset deployment.

-46.40%

Following the Money - Real Cash Generation

Operating Cash Flow

IMRIS Inc. generates limited operating cash flow of $-13.02M, signaling weaker underlying cash strength.

$-13.02M

Free Cash Flow

IMRIS Inc. generates weak or negative free cash flow of $-16.19M, restricting financial flexibility.

$-16.19M

FCF Per Share

Each share generates $-0.26 in free cash annually.

$-0.26

FCF Yield

IMRSQ converts -21661.34% of its market value into free cash.

-21661.34%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.00

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.00

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.00

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.00

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

1.99

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.10

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-1.30

vs 25 benchmark

ROA

Return on assets percentage

-0.46

vs 25 benchmark

ROCE

Return on capital employed

-0.69

vs 25 benchmark

How IMRSQ Stacks Against Its Sector Peers

MetricIMRSQ ValueSector AveragePerformance
P/E Ratio-0.0029.45 Better (Cheaper)
ROE-129.83%779.00% Weak
Net Margin-105.18%-24936.00% (disorted) Weak
Debt/Equity1.990.26 Weak (High Leverage)
Current Ratio1.104.65 Neutral
ROA-46.40%-19344.00% (disorted) Weak

IMRSQ outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews IMRIS Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ